Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
MATSON INCREASES QUARTERLY DIVIDEND TO $0.36 PER SHARE
-
Labcorp to Announce Second Quarter Financial Results on July 24, 2025
-
Virtus Artificial Intelligence & Technology Opportunities Fund Discloses Sources of Distribution – Section 19(a) Notice
-
Teradyne Announces Election of Two New Independent Directors
-
Darling Ingredients Inc. announces offering of €750 million of senior notes by Darling Global Finance B.V., entry into a new amended and restated credit agreement, and redemption of €515.0 million
-
Ranger Energy Services, Inc. Announces Dual Listing on NYSE Texas
-
eXoZymes Selected as Core Industry Partner in $9M NSF-Funded Initiative to Advance Modular Cell-Free Biomanufacturing
-
Earlyworks Co., Ltd. Granted Extension by Nasdaq Hearings Panel to Regain Compliance with Continued Listing Requirements
-
Fiorucci Introduces Crafted Paninos: All-Natural Ingredients and Gourmet Flavor Combinations That Elevate Everyday Snacking
-
Regina Miracle FY25 Net Profit Up by 28.4% to HK$180 Million
-
Limbach Holdings to Participate in CJS Annual New Ideas Summer Conference
-
Starbucks Elects Dambisa Moyo and Marissa Mayer to its Board of Directors
-
Private Water Well Warning Signs: Ben Pearson of Pearson Drilling Company Shares Inspection Tips in HelloNation
-
Grocery Outlet Announces Board Refreshment
-
Lulus Announces Reverse Stock Split
-
Alto Ingredients, Inc. Names Gilbert Nathan Chair, Dianne Nury Vice-Chair and Elects Two New Directors
-
PEOPLES BANCORP INC. TO ANNOUNCE 2ND QUARTER 2025 EARNINGS AND CONDUCT CONFERENCE CALL ON JULY 22, 2025
-
Coveo Named a Leader in the 2025 Gartner® Magic Quadrant™ for Search and Product Discovery
-
Windtree Advances Lower Cost Manufacturing of PHEXXI, Evofem’s Hormone-Free, On-Demand Prescription Contraceptive Gel
-
Realty Income Announces Second Quarter 2025 Earnings Release Date
-
American Outdoor Brands, Inc. Reports Fourth Quarter and Full Fiscal 2025 Financial Results
-
Virtus Diversified Income & Convertible Fund Discloses Sources of Distribution – Section 19(a) Notice
-
Olin Corporation Second Quarter 2025 Earnings Conference Call Announcement
-
Surf Air Mobility Announces Closing of $27 Million Registered Direct Offering of Common Stock
-
Domo Deepens Collaboration with Snowflake to Accelerate AI-Driven Analytics and Data Integration on the AI Data Cloud
-
Werner Enterprises to Release Second Quarter Earnings and Host Earnings Call on July 29, 2025
-
BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Highlights PC111 Breakthrough After Scientist Wins Top Italian Dermatology Award
-
NETSTREIT Corp. Announces Dates for Second Quarter 2025 Earnings Release and Conference Call
-
Fastenal Company Announces Conference Call to Review 2025 Second Quarter Earnings
-
Lesaka and Bank Zero Merge Ambitions in Landmark Transaction
-
Roadzen Reports Full Fiscal Year 2025 Financial Results; Fiscal Q4 Delivers 13.3% Revenue Growth, 99% Net Loss Reduction, and Continued Progress Towards Breakeven
-
Nasdaq to Hold Second Quarter 2025 Investor Conference Call
-
MMA.INC Announces Blockchain and Artificial Intelligence Crypto Rewards Platform through Strategic Web3 Alliance with Morphotech to Revolutionize Martial Arts Engagement and Monetization
-
Regeneron to Report Second Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on August 1, 2025
-
INCOCO CAPITAL SECURES $525M CONSTRUCTION LOAN ON 55-STORY CONDOMINIUM DEVELOPMENT PROJECT IN LIC'S COURT SQUARE
-
Achieve Life Sciences Announces Proposed Underwritten Public Offering
-
Achieve Life Sciences Announces Partnership with Omnicom to Execute Integrated, Data-Driven Launch of the First Potential New Treatment for Nicotine Dependence in Nearly Two Decades
-
Aclaris Therapeutics to Participate in the H.C. Wainwright Inflammation & Immunology Virtual Conference
-
Viper Energy, Inc., a Subsidiary of Diamondback Energy, Inc., Schedules Second Quarter 2025 Conference Call for August 5, 2025
-
Achieve Life Sciences Announces Submission of NDA to FDA for Cytisinicline as a Treatment of Nicotine Dependence for Smoking Cessation
-
Diamondback Energy, Inc. Schedules Second Quarter 2025 Conference Call for August 5, 2025
-
Aclaris Therapeutics to Participate in the H.C. Wainwright Inflammation & Immunology Virtual Conference
-
CorMedix Inc. Announces Proposed Public Offering of Common Stock
-
Devonian Health Group Reports Third Quarter 2025 Financial Results
-
McGrath Second Quarter Earnings and Conference Call Scheduled for July 24, 2025
-
AAPL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Apple Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
RCKT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Rocket Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
RBGLY INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Reckitt Benckiser Group PLC Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
RKT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Rocket Companies, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
LPRO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Open Lending Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
